NEST: A Group Intervention for Parents With Complex PTSD
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSt.Gallen University of Applied Sciences
About this trial
The goal of this pilot clinical trial is to learn whether NEST, a new trauma-informed group therapy program, is feasible and acceptable for parents with Complex PTSD, a condition that can develop after prolonged or repeated traumatic experiences. Parenting can be especially challenging for people with this condition, and few treatment programs currently address this specific need. The main questions it aims to answer are:
* Is the NEST group intervention feasible to deliver and acceptable to parents with Complex PTSD? * Do parents' trauma-related symptoms and their experience of the parenting role change from before to after the intervention?
Participants will:
* Complete online questionnaires about trauma-related symptoms and parenting before the group therapy, after it ends, and again three months later * Take part in nine weekly 90-minute group therapy sessions, co-led by a member of the study team and a mental health professional from the treatment site * Some participants will additionally be invited to a short interview about their experience with the group therapy
Eligibility criteria
Qualifiers
Diagnosis of CPTSD according to ICD-11, confirmed by the treating psychotherapist or psychiatrist
Caregiver of at least one child aged 0-18 years (including biological, adoptive, step-, or foster parents and other primary caregivers)
Currently receiving individual psychotherapeutic treatment (outpatient or inpatient setting)
Age 18 years or older
Disqualifiers
Current acute psychosis or severe psychiatric instability requiring immediate intensive treatment
Severe cognitive impairment or inability to participate adequately in group-based procedures
No current contact with the child
Insufficient German language proficiency
Trial design
Treatments tested in this trial
- Trauma-Informed Parenting Group Intervention
Treatment groups
32 Participants
are divided into 1 treatment groupSponsors and collaborators
St.Gallen University of Applied Sciences
Lead sponsor
Swiss National Science Foundation
Collaborator
Source ClinicalTrials.gov